Efficacy News and Research

RSS
Phase I NSCLC trials shrink and cluster in major U.S. cities

Phase I NSCLC trials shrink and cluster in major U.S. cities

Muscle energy recovery may explain fatigue in cancer survivors

Muscle energy recovery may explain fatigue in cancer survivors

Trial shows safety of novel KIR-CAR T therapy in solid tumors

Trial shows safety of novel KIR-CAR T therapy in solid tumors

Single CAR T infusion shows strong response in smoldering multiple myeloma patients

Single CAR T infusion shows strong response in smoldering multiple myeloma patients

Targeting glutamine metabolism enhances CAR-macrophage cancer therapy

Targeting glutamine metabolism enhances CAR-macrophage cancer therapy

CBD shows promise, but this review warns the hype is outpacing the science

CBD shows promise, but this review warns the hype is outpacing the science

Your new therapist: Chatty, leaky, and hardly human

Your new therapist: Chatty, leaky, and hardly human

Donor-derived dendritic cells teach the immune system to accept new livers

Donor-derived dendritic cells teach the immune system to accept new livers

Concerns rise over breast cancer risk and gender-based efficacy of Ocrevus

Concerns rise over breast cancer risk and gender-based efficacy of Ocrevus

Scientists link poor sleep to decreased chemotherapy response via the gut

Scientists link poor sleep to decreased chemotherapy response via the gut

Why AI is becoming a powerful tool in cancer drug discovery

Why AI is becoming a powerful tool in cancer drug discovery

Researchers prove magnetic seizures are comparable to ECT in clinical response

Researchers prove magnetic seizures are comparable to ECT in clinical response

Sunlight exposure via windows risks infant dehydration and skin damage

Sunlight exposure via windows risks infant dehydration and skin damage

New lab-grown organoids accurately mimic pediatric brain tumor biology

New lab-grown organoids accurately mimic pediatric brain tumor biology

Dutch study shows off-label targeted therapies benefit more cancer patients

Dutch study shows off-label targeted therapies benefit more cancer patients

Brain organoids reveal mutation-specific insights for Rett syndrome

Brain organoids reveal mutation-specific insights for Rett syndrome

ORGAPRED selects CYTOQUBE® from Hamamatsu Photonics for personalized oncology research and therapeutic discovery

ORGAPRED selects CYTOQUBE® from Hamamatsu Photonics for personalized oncology research and therapeutic discovery

VALANX Biotech establishes Scientific Advisory Board to advance ADC therapeutics

VALANX Biotech establishes Scientific Advisory Board to advance ADC therapeutics

A new model to break the cycle of chronic nightmares in children

A new model to break the cycle of chronic nightmares in children

Beetroot supplement raises nitric oxide markers in triathletes after one week

Beetroot supplement raises nitric oxide markers in triathletes after one week

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.